Home
→
Browsing by Author

Browsing by Author "Isla, Dolores"

Now showing items 1-4 of 4

Addition of immune checkpoint inhibitors to chemotherapy vs chemotherapy alone as first-line treatment in extensive-stage small-cell lung carcinoma: a systematic review and meta-analysis

Arriola Aperribay, Edurne; González Cao, María; Domine, Manuel; De Castro, Javier; Cobo, Manuel; Bernabé, Reyes; Navarro, Alejandro; Sullivan, Ivana; Trigo, José Manuel; Mosquera, Joaquín; Crama, Leonardo; Isla, Dolores (Springer, 2022)

Introduction: The addition of immune checkpoint inhibitors (ICIs) to conventional chemotherapy (CT) as first-line treatment improves survival in extensive-stage small-cell lung cancer (ES-SCLC). The aim of this meta-analysis ...
Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain

Arriola Aperribay, Edurne; García Gómez, Ramón; Diz Tain, Pilar; Majem, Margarita; Martínez Aguillo, Maite; Valdivia, Javier; Paredes, Alfredo; Sánchez-Torres, José Miguel; Peralta Muñoz, Sergio; Barneto, Isidoro; Gutierrez, Vanesa; Andrade Santiago, Jesús Manuel; Aparisi, Francisco; Isla, Dolores; Ponce, Santiago; Vicente Baz, David; Artal, Angel; Amador, Mariluz; Provencio, Mariano (BioMed Central, 2018)

BACKGROUND: Although the benefit of first-line epidermal growth factor receptor (EGFR) tyrosine-kinase inhibitors (TKIs) over chemotherapy has been demonstrated in several clinical trials, data from clinical practice is ...
Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer

Isla, Dolores; De Castro, Javier; Juan, Oscar; Grau Cerrato, Santiago; Orofino, Javier; Gordo, Rocío; Rubio-Terrés, Carlos; Rubio-Rodríguez, Darío (Dove Medical Press, 2016)

OBJECTIVES: Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are an established treatment for advanced non-small cell lung cancer (NSCLC) with EGFR mutation. According to published meta-analyses, no ...
Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Garrido, P.; Conde, Esther; De Castro, Javier; Gómez-Román, J. J.; Felip, Enriqueta; Pijuan Andujar, Lara; Isla, Dolores; Sanz, J.; Paz-Ares, L.; López-Ríos, F. (Springer, 2020)

In 2011 the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP) started a joint project to establish guidelines on biomarker testing in patients with advanced non-small-cell lung cancer ...

Now showing items 1-4 of 4

Search DSpace

Advanced Search

Browse

All of DSpace

My Account

In collaboration with Compliant to Partaking

Browsing by Author "Isla, Dolores"

Browsing by Author "Isla, Dolores"

Search DSpace

Browse

All of DSpace

My Account